Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3537-3542

  Eggers, Kai M ^a   Venge, Per ^a   Lindahl, Bertil ^a   Lind, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adrenomedullin; Biomarkers; General population; Mortality; Risk prediction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; PROADRENOMEDULLIN; TRIACYLGLYCEROL;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

ADRENOMEDULLIN; BIOMARKERS; GENERAL POPULATION; MORTALITY; RISK PREDICTION;

ADRENOMEDULLIN; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC DISEASES; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; SWEDEN; VASODILATION;

EID: 84886248690     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.05.005     Document Type: Article

References (29)

1. J. Kato, T. Tsuruda, T. Kita, K. Kitamura, and T. Eto Adrenomedullin. A protective factor for blood vessels Arterioscler Thromb Vasc Biol 25 2005 2480 2487
2. T. Ishimitsu, H. Ono, J. Minami, and H. Matsuoka Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders Pharmacol Ther 111 2006 909 927
3. C. Adlbrecht, M. Hülsmann, and G. Strunk Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients Eur Heart J 11 2009 361 366
4. S. von Haehling, G.S. Filippatos, and J. Papassotiriou Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure Eur J Heart Fail 12 2010 484 491
5. A. Maisel, C. Mueller, and R. Nowak Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
6. R.B. Schnabel, A. Schulz, and C.M. Messow Multiple marker approach to risk stratification in patients with stable coronary artery disease Eur Heart J 31 2010 3024 3031
7. O.S. Dhillon, S.Q. Khan, and H.K. Narayan Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study J Am Coll Cardiol 56 2010 125 133
8. Y. Suzuki, T. Horio, and T. Hayashi Plasma adrenomedullin concentration is increased in patients with peripheral arterial occlusive disease associated with vascular inflammation Regul Pept 118 2004 99 104
9. O. Melander, C. Newton-Cheh, and P. Almgren Novel and conventional biomarkers for prediction of incident cardiovascular events in the community JAMA 302 2009 49 57
10. S. Blankenberg, T. Zeller, and O. Saarela Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) biomarker project Circulation 121 2010 2388 2397
11. L. Lind, N. Fors, J. Hall, K. Marttala, and A. Stenborg A comparison of three different methods to evaluate endothelium-dependent vasodilatation in the elderly. The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study Arterioscler Thromb Vasc Biol 25 2005 2368 2375
12. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 2005 1823 1829
13. K.M. Eggers, L. Lind, and H. Ahlström Prevalence and pathophysiologic mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects Eur Heart J 29 2008 2252 2258
14. A.S. Levey, T. Greene, J.W. Kusek, G.J. Beck, and MDRD Study Group A simplified equation to predict glomerular filtration rate from serum creatinine J Am Soc Nephrol 11 2000 155A
15. J. Sundström, J. Arnlöv, K. Stolare, and L. Lind Blood pressure-independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance: a population-based study Heart 94 2008 874 878
16. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Working Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
17. L. Lind, N. Fors, J. Hall, K. Marttala, and A. Stenborg A comparison of three different methods to determine arterial compliance in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study J Hypertens 24 2006 1075 1082
18. L. Lind, J. Andersson, M. Rönn, and T. Gustavsson The echogenecity of the intima-media complex in the common carotid artery is closely related to the echogenecity in plaques Atherosclerosis 195 2007 411 414
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
20. H. Blackburn, A. Keys, E. Simonson, P. Rautaharju, and S. Punsar The electrocardiogram in population studies. A classification system Circulation 21 1960 1160 1175
21. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
22. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
23. Q.A. Truong, E. Siegel, and M. Karakas Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT trial Clin Chem 56 2010 651 660
24. S.S. Bhandari, J.E. Davies, J. Struck, and L.L. Ng The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension Metabolism 59 2010 7 13
25. J.G. Smith, C. Newton-Cheh, and B. Hedblad Distribution and correlates of midregional proadrenomedullin in the general population Clin Chem 55 2009 1593 1595
26. S.S. Bhandari, J.E. Davies, J. Struck, and L.L. Ng Influence of confounding factors on plasma mid-regional pro-adrenomedullin and mid-regional pro-A-type natriuretic peptide in healthy individuals Biomarkers 16 2011 281 287
27. Y. Li, C. Jiang, X. Wang, Y. Zhang, S. Shibahara, and K. Takahashi Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues Peptides 28 2007 1129 1143
28. M.S. Sabatine, D.A. Morrow, and J.A. de Lemos Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease Circulation 125 2012 233 240
29. S. Neuhold, M. Huelsmann, and G. Strunk Prognostic value of emerging neurohormones in chronic heart failure during optimization of heart failure-specific therapy Clin Chem 56 2010 121 126